Pontifax
2 rounds tracked since 15 October 2025.
- Rounds
- 2
- Led
- 0
- Capital in these rounds
- $166M
Sectors
Countries
Rounds
- AdcytherixAntibody-drug conjugates for cancer built on novel payloads $122MSeries A · 16 Oct
- Step PharmaClinical-stage biotech developing CTPS1 inhibitor dencatistat for cancers $44.2MSeries C · 15 Oct
No round matches these filters.